The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
Open accessAbstract
The Raf-1 protein kinase is the best-characterized downstream effector of activated Ras. Interaction with Ras leads to Raf-1 activation and results in transduction of cell growth and differentiation signals. The details of Raf-1 activation are unclear, but our characterization of a second Ras-binding site in the cysteine-rich domain (CRD) and the involvement of both Ras-binding sites in effective Raf-1-mediated transformation provides insight into the molecular aspects and consequences of Ras-Raf interactions. The Raf-1 CRD is a member of an emerging family of domains, many of which are found within signal transducing proteins. Several contain binding sites for diacylglycerol (or phorbol esters) and phosphatidylserine and are believed to play a role in membrane translocation and enzyme activation. The CRD from Raf-1 does not bind diacylglycerol but interacts with Ras and phosphatidylserine. To investigate the ligand-binding specificities associated with CRDs, we have determined the solution structure of the Raf-1 CRD using heteronuclear multidimensional NMR. We show that there are differences between this structure and the structures of two related domains from protein kinase C (PKC). The differences are confined to regions of the CRDs involved in binding phorbol ester in the PKC domains. Since phosphatidylserine is a common ligand, we expect its binding site to be located in regions where the structures of the Raf-1 and PKC domains are similar. The structure of the Raf-1 CRD represents an example of this family of domains that does not bind diacylglycerol and provides a framework for investigating its interactions with other molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iterative schemes for bilinear operators; application to spin decoupling
Shaka, A. J., Lee, C. J., & Pines, A. (1988) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(88)90178-3 · Cited by 745
Raf meets Ras: completing the framework of a signal transduction pathway
Avruch, J., Zhang, X.-F., & Kyriakis, J. M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90005-1 · Cited by 577
Cited by
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,475
Newton, A. C. (2001) · Chemical Reviews · doi:10.1021/cr0002801 · Cited by 962
Regulation of protein kinase C
Newton, A. C. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80058-0 · Cited by 914
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
Aplin, A. E., Howe, A., Alahari, S. K., & Juliano, R. L. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01359-0 · Cited by 847
Zinc coordination sphere in biochemical zinc sites
Auld, D. S. (2001) · Biometals · doi:10.1023/a:1012976615056 · Cited by 721
Regulation of RAF protein kinases in ERK signalling
Lavoie, H., & Therrien, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3979 · Cited by 702
The complexity of Raf-1 regulation
Morrison, D. K., & Cutler, R. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80060-9 · Cited by 635
Tumor adaptation and resistance to RAF inhibitors
Lito, P., Rosen, N., & Solit, D. B. (2013) · Nature Medicine · doi:10.1038/nm.3392 · Cited by 585
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Degirmenci, U., Wang, M., & Hu, J. (2020) · Cells · doi:10.3390/cells9010198 · Cited by 534
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Raf Family Kinases: Old Dogs Have Learned New Tricks
Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W. (2011) · Genes & Cancer · doi:10.1177/1947601911407323 · Cited by 386
Exposure of platelet membrane phosphatidylserine regulates blood coagulation
Lentz, B. R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00025-0 · Cited by 371
Taxonomy and function of C1 protein kinase C homology domains
Hurley, J. H., Newton, A. C., Parker, P. J., Blumberg, P. M., & Nishizuka, Y. (1997) · Protein Science · doi:10.1002/pro.5560060228 · Cited by 362
“ture (Mott et al., 1996) of the atypical CI domain of Raf-1 shows an even more dramatic variation from the typical CI domains:”
BackgroundStructural Basis of Rab Effector Specificity
Ostermeier, C., & Brunger, A. T. (1999) · Cell · doi:10.1016/s0092-8674(00)80549-8 · Cited by 340
Raf kinases: Function, regulation and role in human cancer
Leicht, D. T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., & Tzivion, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.001 · Cited by 317
Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes
Park, E., Rawson, S., Li, K., Kim, B.-W., Ficarro, S. B., Pino, G. G.-D., Sharif, H., Marto, J. A., Jeon, H., & Eck, M. J. (2019) · Nature · doi:10.1038/s41586-019-1660-y · Cited by 309
C1 domains exposed: From diacylglycerol binding to protein–protein interactions
COLONGONZALEZ, F., & KAZANIETZ, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.05.001 · Cited by 308
Protein kinase C: a paradigm for regulation of protein function by two membrane-targeting modules
Newton, A. C., & Johnson, J. E. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00003-3 · Cited by 274
Amphitropic proteins: regulation by reversible membrane interactions (Review)
Johnson, J. E., & Cornell, R. B. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294544 · Cited by 266
Signaling and Subcellular Targeting by Membrane-Binding Domains
Hurley, J. H., & Misra, S. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.49 · Cited by 261
Activation of c-Raf Kinase by Ultraviolet Light
Hoyos, B., Imam, A., Korichneva, I., Levi, E., Chua, R., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110750200 · Cited by 55
Ma, Y., Gu, Y., Zhang, Q., Han, Y., Yu, S., Lu, Z., & Chen, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0650 · Cited by 55
“However, the Raf-1 RBD alone is not sufficient to support a stable interaction with Ras in living cells, the addition of the cysteine-rich domain (CRD) is required for the RBD to remain bound to active Ras and form a more stable complex in the plasma membrane (24-26).”
BackgroundMicrotubule Integrity Regulates Pak Leading to Ras-independent Activation of Raf-1
Zang, M., Waelde, C. A., Xiang, X., Rana, A., Wen, R., & Luo, Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100152200 · Cited by 48
López, C. A., Zhang, X., Aydin, F., Shrestha, R., Van, Q. N., Stanley, C. B., Carpenter, T. S., Nguyen, K., Patel, L. A., Chen, D., et al. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00168 · Cited by 18
Metadata
- Authors
- Mott, H. R., Carpenter, J. W., Zhong, S., Ghosh, S., Bell, R. M., & Campbell, S. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-08-06
- Volume
- 93
- Issue
- 16
- Pages
- 8312-8317
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1995603763
- Cited by
- 199
- References
- 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.